News

Medigene expands patent protection of its technologies in key markets, the USA and Europe

SHOW RELEASE

Participation at upcoming virtual conferences

SHOW RELEASE

Dr. Anthony Man appointed to Supervisory Board

SHOW RELEASE

PRAME expression and HLA genotype screening in AML and MDS patients

SHOW RELEASE

Detailed analysis from Medigene's completed Phase I/II DC vaccine in AML patients presented orally at ASH 2020

SHOW RELEASE

Medigene provides Q3 2020 update

SHOW RELEASE

Medigene's MAGE-A4-specific TCR-Ts detect and fight cancer cells independent of CD8 co-receptor

SHOW RELEASE

Medigene's PD1-41BB switch receptor effectively enhances TCR-T cells to fight solid tumors

SHOW RELEASE

Positive Phase I/II trial feasibility results - Consistent high-quality DC vaccines in AML patients

SHOW RELEASE

Oral and poster presentations on Medigene's clinical research at ASH conference

SHOW RELEASE

Medigene and Cytovant enter into service agreement for DC vaccine manufacturing process development

SHOW RELEASE

Three Medigene poster presentations at SITC Annual Meeting

SHOW RELEASE

Medigene expands patent protection of its technologies

SHOW RELEASE

Medigene participates at upcoming virtual conferences

SHOW RELEASE

Strategic measures including restructuring with extension of cash runway and improved EBITDA

SHOW RELEASE